Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gene Rearrangement | 6 | 2019 | 1208 | 0.830 |
Why?
|
Gene Fusion | 3 | 2018 | 376 | 0.690 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2020 | 3698 | 0.530 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2020 | 732 | 0.490 |
Why?
|
Bile Duct Neoplasms | 2 | 2020 | 580 | 0.490 |
Why?
|
Codon | 2 | 2013 | 616 | 0.480 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2013 | 43 | 0.480 |
Why?
|
Apocrine Glands | 1 | 2012 | 28 | 0.470 |
Why?
|
Genes, Neoplasm | 2 | 2014 | 392 | 0.470 |
Why?
|
Eccrine Glands | 1 | 2012 | 51 | 0.460 |
Why?
|
PTEN Phosphohydrolase | 3 | 2015 | 1160 | 0.450 |
Why?
|
Caveolin 1 | 1 | 2013 | 257 | 0.430 |
Why?
|
Chordoma | 2 | 2014 | 387 | 0.420 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2018 | 609 | 0.420 |
Why?
|
Thyroid Neoplasms | 4 | 2015 | 2229 | 0.360 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2017 | 1393 | 0.360 |
Why?
|
Cholangiocarcinoma | 1 | 2014 | 526 | 0.360 |
Why?
|
Germinal Center | 1 | 2011 | 372 | 0.360 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2013 | 662 | 0.360 |
Why?
|
Carcinoma | 3 | 2015 | 2325 | 0.320 |
Why?
|
Lung Neoplasms | 9 | 2018 | 12608 | 0.310 |
Why?
|
Pancreatic Cyst | 3 | 2016 | 348 | 0.310 |
Why?
|
Gene Dosage | 1 | 2011 | 1270 | 0.300 |
Why?
|
Chromosome Aberrations | 3 | 2013 | 1826 | 0.290 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 7 | 2018 | 4955 | 0.280 |
Why?
|
Lymphoma, B-Cell | 1 | 2011 | 937 | 0.270 |
Why?
|
Sequence Analysis, DNA | 3 | 2018 | 4916 | 0.270 |
Why?
|
Mutation | 15 | 2020 | 29491 | 0.270 |
Why?
|
In Situ Hybridization, Fluorescence | 6 | 2019 | 2661 | 0.260 |
Why?
|
Lactams, Macrocyclic | 2 | 2016 | 328 | 0.260 |
Why?
|
Cytodiagnosis | 2 | 2016 | 420 | 0.220 |
Why?
|
Glioblastoma | 2 | 2014 | 3357 | 0.220 |
Why?
|
Pyrazoles | 4 | 2016 | 1976 | 0.220 |
Why?
|
Protein Kinase Inhibitors | 8 | 2018 | 5495 | 0.220 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2019 | 1615 | 0.210 |
Why?
|
Bile Ducts | 2 | 2020 | 291 | 0.210 |
Why?
|
Immunohistochemistry | 4 | 2013 | 11777 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2017 | 997 | 0.190 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2016 | 1635 | 0.190 |
Why?
|
Pyridines | 3 | 2016 | 2871 | 0.180 |
Why?
|
Cyst Fluid | 2 | 2016 | 69 | 0.180 |
Why?
|
Thrombocytosis | 1 | 2018 | 87 | 0.170 |
Why?
|
Granuloma, Plasma Cell | 1 | 2019 | 88 | 0.170 |
Why?
|
Oncogene Fusion | 2 | 2017 | 110 | 0.170 |
Why?
|
RNA-Binding Protein EWS | 1 | 2019 | 210 | 0.170 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2018 | 5271 | 0.160 |
Why?
|
DNA-Binding Proteins | 2 | 2014 | 9804 | 0.160 |
Why?
|
Genes, p53 | 2 | 2020 | 768 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2015 | 15600 | 0.160 |
Why?
|
Paraffin Embedding | 2 | 2014 | 319 | 0.150 |
Why?
|
Cystadenoma, Mucinous | 1 | 2016 | 57 | 0.150 |
Why?
|
Cystadenoma | 2 | 2015 | 84 | 0.150 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2019 | 263 | 0.150 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2017 | 1308 | 0.150 |
Why?
|
Comparative Genomic Hybridization | 3 | 2012 | 514 | 0.140 |
Why?
|
Transcription Factors | 2 | 2014 | 12073 | 0.140 |
Why?
|
Receptor, trkA | 1 | 2015 | 160 | 0.130 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2014 | 60 | 0.130 |
Why?
|
Adenocarcinoma | 3 | 2019 | 6370 | 0.130 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 791 | 0.130 |
Why?
|
Indazoles | 1 | 2015 | 293 | 0.130 |
Why?
|
Neoplasm Proteins | 3 | 2016 | 3778 | 0.130 |
Why?
|
High-Throughput Screening Assays | 2 | 2017 | 942 | 0.120 |
Why?
|
Biliary Tract Neoplasms | 1 | 2015 | 176 | 0.120 |
Why?
|
Genetic Testing | 2 | 2019 | 3340 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 628 | 0.120 |
Why?
|
Frameshift Mutation | 1 | 2015 | 398 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2972 | 0.120 |
Why?
|
Hepatoblastoma | 1 | 2013 | 84 | 0.120 |
Why?
|
Exons | 2 | 2016 | 2480 | 0.120 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2015 | 195 | 0.120 |
Why?
|
Neoplasms, Adnexal and Skin Appendage | 1 | 2013 | 23 | 0.120 |
Why?
|
Pancreatic Neoplasms | 3 | 2015 | 5022 | 0.120 |
Why?
|
Mutagenesis, Insertional | 1 | 2015 | 664 | 0.120 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2013 | 103 | 0.120 |
Why?
|
Fibromatosis, Aggressive | 1 | 2013 | 115 | 0.120 |
Why?
|
Myeloproliferative Disorders | 1 | 2018 | 607 | 0.110 |
Why?
|
Smad4 Protein | 3 | 2020 | 168 | 0.110 |
Why?
|
Burkitt Lymphoma | 1 | 2014 | 365 | 0.110 |
Why?
|
RNA, Guide | 1 | 2014 | 303 | 0.110 |
Why?
|
Medical Informatics | 2 | 2016 | 738 | 0.110 |
Why?
|
Nevus, Blue | 1 | 2011 | 36 | 0.110 |
Why?
|
Liver Neoplasms | 3 | 2017 | 4102 | 0.110 |
Why?
|
Aged | 24 | 2019 | 162862 | 0.100 |
Why?
|
beta Catenin | 2 | 2014 | 1046 | 0.100 |
Why?
|
Wilms Tumor | 1 | 2013 | 339 | 0.100 |
Why?
|
Melanoma | 3 | 2017 | 5260 | 0.100 |
Why?
|
Genomics | 3 | 2017 | 5338 | 0.100 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2017 | 8685 | 0.100 |
Why?
|
Middle Aged | 27 | 2019 | 215054 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2017 | 1671 | 0.100 |
Why?
|
Humans | 49 | 2020 | 717280 | 0.100 |
Why?
|
Parietal Lobe | 1 | 2015 | 820 | 0.100 |
Why?
|
Neutrophil Infiltration | 1 | 2013 | 401 | 0.100 |
Why?
|
Pathology, Clinical | 1 | 2014 | 372 | 0.100 |
Why?
|
Introns | 1 | 2013 | 1016 | 0.100 |
Why?
|
Female | 36 | 2019 | 377934 | 0.100 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2014 | 588 | 0.100 |
Why?
|
NIH 3T3 Cells | 1 | 2011 | 700 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2015 | 833 | 0.090 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2011 | 359 | 0.090 |
Why?
|
Benzamides | 1 | 2015 | 1414 | 0.090 |
Why?
|
Hamartoma | 1 | 2011 | 232 | 0.090 |
Why?
|
Aged, 80 and over | 13 | 2019 | 58528 | 0.090 |
Why?
|
Mutant Proteins | 1 | 2011 | 514 | 0.090 |
Why?
|
Chromosome Deletion | 1 | 2014 | 1378 | 0.090 |
Why?
|
Gene Frequency | 2 | 2015 | 3714 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 486 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2018 | 2555 | 0.090 |
Why?
|
Nevus, Pigmented | 1 | 2011 | 218 | 0.090 |
Why?
|
Skin Neoplasms | 3 | 2013 | 5335 | 0.090 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2014 | 750 | 0.090 |
Why?
|
Drug Discovery | 1 | 2017 | 1071 | 0.090 |
Why?
|
Mosaicism | 1 | 2011 | 452 | 0.090 |
Why?
|
Adult | 23 | 2019 | 212470 | 0.090 |
Why?
|
Gadolinium | 1 | 2013 | 910 | 0.080 |
Why?
|
Male | 29 | 2019 | 351399 | 0.080 |
Why?
|
Genes, p16 | 2 | 2020 | 160 | 0.080 |
Why?
|
Microsatellite Instability | 1 | 2011 | 672 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2016 | 8944 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2014 | 6294 | 0.080 |
Why?
|
Carcinoma, Papillary | 1 | 2012 | 797 | 0.080 |
Why?
|
Barrett Esophagus | 1 | 2011 | 486 | 0.080 |
Why?
|
Biopsy | 5 | 2020 | 6753 | 0.080 |
Why?
|
Terminology as Topic | 1 | 2014 | 1620 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2016 | 1949 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3565 | 0.070 |
Why?
|
Fibrosis | 1 | 2013 | 1964 | 0.070 |
Why?
|
Myelodysplastic Syndromes | 1 | 2015 | 1267 | 0.070 |
Why?
|
Lactams | 2 | 2016 | 158 | 0.070 |
Why?
|
Computational Biology | 2 | 2017 | 3568 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2485 | 0.070 |
Why?
|
Carcinoembryonic Antigen | 2 | 2016 | 350 | 0.070 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2015 | 1521 | 0.070 |
Why?
|
Skin Diseases | 1 | 2013 | 1090 | 0.060 |
Why?
|
Young Adult | 10 | 2019 | 56249 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 2 | 2014 | 4697 | 0.060 |
Why?
|
Neoplasms | 3 | 2019 | 20572 | 0.060 |
Why?
|
DNA Mutational Analysis | 4 | 2014 | 4312 | 0.060 |
Why?
|
Blotting, Western | 1 | 2011 | 5438 | 0.060 |
Why?
|
Crohn Disease | 1 | 2016 | 2255 | 0.060 |
Why?
|
Sulfones | 2 | 2016 | 459 | 0.060 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4928 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2907 | 0.060 |
Why?
|
Gene Amplification | 2 | 2018 | 1079 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2015 | 8805 | 0.060 |
Why?
|
Receptor, erbB-2 | 1 | 2012 | 2333 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2013 | 3008 | 0.060 |
Why?
|
Aminopyridines | 2 | 2016 | 544 | 0.060 |
Why?
|
Genetic Variation | 2 | 2017 | 6664 | 0.050 |
Why?
|
Software | 1 | 2016 | 4367 | 0.050 |
Why?
|
Workflow | 2 | 2017 | 817 | 0.050 |
Why?
|
GTP Phosphohydrolases | 2 | 2016 | 516 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 908 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2011 | 1535 | 0.050 |
Why?
|
Fibroblasts | 1 | 2011 | 4286 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2015 | 3333 | 0.050 |
Why?
|
Contrast Media | 1 | 2013 | 5278 | 0.050 |
Why?
|
Genetic Heterogeneity | 2 | 2014 | 751 | 0.050 |
Why?
|
Ki-67 Antigen | 2 | 2011 | 629 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2017 | 3697 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12484 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11336 | 0.040 |
Why?
|
Thyroidectomy | 2 | 2015 | 893 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 4874 | 0.040 |
Why?
|
Cytogenetic Analysis | 1 | 2018 | 308 | 0.040 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2019 | 261 | 0.040 |
Why?
|
Vision Disorders | 2 | 2015 | 1038 | 0.040 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2017 | 212 | 0.040 |
Why?
|
Receptors, Steroid | 1 | 2017 | 156 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-raf | 1 | 2017 | 207 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2019 | 1902 | 0.040 |
Why?
|
Disease Progression | 3 | 2019 | 13308 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2011 | 796 | 0.040 |
Why?
|
K562 Cells | 1 | 2018 | 637 | 0.040 |
Why?
|
Genome, Human | 3 | 2015 | 4472 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11200 | 0.040 |
Why?
|
Neuregulin-1 | 1 | 2017 | 141 | 0.040 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2018 | 430 | 0.040 |
Why?
|
DNA, Neoplasm | 2 | 2012 | 1779 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6590 | 0.040 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2017 | 218 | 0.040 |
Why?
|
Paraffin | 1 | 2014 | 35 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2017 | 374 | 0.030 |
Why?
|
Phenotype | 1 | 2013 | 16404 | 0.030 |
Why?
|
Biliary Tract | 1 | 2015 | 140 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2013 | 21811 | 0.030 |
Why?
|
Chromogranins | 1 | 2015 | 174 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2015 | 605 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2017 | 6777 | 0.030 |
Why?
|
Aphasia | 1 | 2015 | 175 | 0.030 |
Why?
|
Preoperative Period | 1 | 2016 | 557 | 0.030 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2015 | 327 | 0.030 |
Why?
|
Liver Failure | 1 | 2015 | 234 | 0.030 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2015 | 284 | 0.030 |
Why?
|
Quality Control | 1 | 2017 | 869 | 0.030 |
Why?
|
Pyrimidines | 2 | 2016 | 2974 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2016 | 804 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2014 | 257 | 0.030 |
Why?
|
Estrogen Receptor alpha | 1 | 2017 | 583 | 0.030 |
Why?
|
Keratin-19 | 1 | 2013 | 33 | 0.030 |
Why?
|
RNA Editing | 1 | 2014 | 160 | 0.030 |
Why?
|
Keratin-17 | 1 | 2013 | 26 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2014 | 740 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2015 | 217 | 0.030 |
Why?
|
Signal Transduction | 1 | 2017 | 23997 | 0.030 |
Why?
|
Formaldehyde | 1 | 2014 | 366 | 0.030 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2015 | 490 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14904 | 0.030 |
Why?
|
Pyridones | 1 | 2017 | 687 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2014 | 7056 | 0.030 |
Why?
|
Vincristine | 1 | 2014 | 1043 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 1928 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2669 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 29226 | 0.030 |
Why?
|
Adolescent | 6 | 2019 | 85143 | 0.030 |
Why?
|
Survival Analysis | 2 | 2016 | 10542 | 0.030 |
Why?
|
Base Sequence | 2 | 2015 | 13317 | 0.030 |
Why?
|
Child, Preschool | 4 | 2019 | 41221 | 0.030 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 713 | 0.030 |
Why?
|
Mice, SCID | 1 | 2017 | 2845 | 0.030 |
Why?
|
Craniotomy | 1 | 2015 | 728 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2020 | 3018 | 0.030 |
Why?
|
Brain Edema | 1 | 2015 | 617 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2016 | 1904 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 17432 | 0.030 |
Why?
|
Pathology, Molecular | 1 | 2014 | 346 | 0.030 |
Why?
|
Molecular Structure | 1 | 2015 | 1990 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits | 1 | 2011 | 96 | 0.030 |
Why?
|
Mice, Nude | 1 | 2017 | 3830 | 0.020 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2011 | 134 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20086 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2016 | 662 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2017 | 16989 | 0.020 |
Why?
|
Quinazolines | 1 | 2017 | 1424 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1548 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2019 | 19537 | 0.020 |
Why?
|
Mice | 2 | 2017 | 81128 | 0.020 |
Why?
|
Chromatin | 1 | 2020 | 2741 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2013 | 1551 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2193 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2017 | 2593 | 0.020 |
Why?
|
Pancreas | 1 | 2015 | 1693 | 0.020 |
Why?
|
Indoles | 1 | 2017 | 1859 | 0.020 |
Why?
|
Child | 4 | 2019 | 74388 | 0.020 |
Why?
|
Oncogenes | 1 | 2014 | 1259 | 0.020 |
Why?
|
Melanocytes | 1 | 2011 | 523 | 0.020 |
Why?
|
Genes, ras | 1 | 2011 | 720 | 0.020 |
Why?
|
Doxorubicin | 1 | 2014 | 2235 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2016 | 8109 | 0.020 |
Why?
|
Sulfonamides | 1 | 2017 | 1932 | 0.020 |
Why?
|
Research | 1 | 2016 | 2023 | 0.020 |
Why?
|
Animals | 3 | 2017 | 170894 | 0.020 |
Why?
|
Pancreatectomy | 1 | 2012 | 855 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2017 | 4921 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1988 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2014 | 1800 | 0.020 |
Why?
|
Binding Sites | 1 | 2015 | 6295 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 3963 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39302 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2013 | 13276 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2721 | 0.020 |
Why?
|
Risk Factors | 1 | 2013 | 70863 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2269 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2017 | 5101 | 0.020 |
Why?
|
Cell Survival | 1 | 2016 | 6133 | 0.020 |
Why?
|
ras Proteins | 1 | 2011 | 1117 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2011 | 1056 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2716 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2012 | 2975 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2014 | 2961 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13613 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 6051 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2865 | 0.020 |
Why?
|
Alleles | 1 | 2015 | 7101 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2016 | 3472 | 0.010 |
Why?
|
Prospective Studies | 2 | 2019 | 51277 | 0.010 |
Why?
|
Cohort Studies | 2 | 2015 | 39891 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4102 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 15258 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 8013 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2019 | 72608 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2016 | 10802 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 16693 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 62344 | 0.010 |
Why?
|
Skin | 1 | 2013 | 4355 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 8948 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12923 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 9532 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2013 | 15271 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 14899 | 0.010 |
Why?
|
Time Factors | 1 | 2018 | 41094 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 12435 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 23543 | 0.010 |
Why?
|
Infant | 1 | 2011 | 34574 | 0.010 |
Why?
|